InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.00%
)
US TECH 100
19,366.00
(
0.53%
)
Dow Jones
39,164.06
(
0.00%
)
Brent Oil
85.55
(
0.15%
)
Bitcoin
61,541.67
(
-0.11%
)
Post# of 21536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

grich1

Send PM Follow Ignore
Followers 6
Posts 852
Boards Moderated 0
Alias Born 03/07/2017

grich1

Re: None

Friday, 06/14/2019 11:04:32 PM

Friday, June 14, 2019 11:04:32 PM

Post# of 21536
Our Chief Scientific Officer Dr. Daniel Alkon interviewed today for @featurestory @danielryntjes. #Bryostatin is the only drug in development for moderate to severe #Alzheimer's Disease.
Confirmatory Phase 2 data released late summer.
#WeAreNeurotrope #Bryostatin #Alzheimers

On Twitter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!